Prostate Cancer

Growth Factor Levels Indicate Likelihood Of Metastasis

Published in Cancer Weekly, June 26th, 2001

Elevated levels of a growth factor indicate which men diagnosed with prostate cancer are likely to need more aggressive treatment, researchers at Baylor College of Medicine have discovered.

"This marker, measured through a simple blood test, indicates at a very early stage which patients may have prostate cancer that has already begun to spread to other areas of the body," said Dr. Kevin Slawin, associate professor of urology and director of the Baylor Prostate Center, Houston, Texas. "It can give us an early warning for who will need more aggressive therapy."

The findings, which describe the association of transforming growth factor beta, or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-06-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry